A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments, including ...

The first CAR-T cell therapy was developed and approved by the FDA in 2017 to treat relapsed or refractory B-cell precursor ...

A next-generation “armored” CAR T cell therapy showed promising results in a small ... While CAR T cell therapy—a personalized form of cancer immunotherapy first successfully developed by Carl June, ...

A next-generation "armored" CAR T cell therapy showed promising results in a small ... While CAR T cell therapy -- a personalized form of cancer immunotherapy first successfully developed by Carl June ...

A next-generation "armored" CAR T cell therapy showed promising results ... While CAR T cell therapy—a personalized form of cancer immunotherapy first successfully developed by Carl June ...

An authentic World War II Sherman tank will lead a parade of vintage military armored vehicles in the Old Bethpage-based ...

PHILADELPHIA – A next-generation “armored” CAR T cell therapy ... evolution of CAR T cell therapy, as the first time a cytokine-enhanced CAR T has been tested in patients with blood cancer.

RICHMOND, Va. (AP) — RICHMOND, Va. (AP) — Brink’s Co. (BCO) on Monday reported first-quarter net income of $51.6 million. On a per-share basis, the Richmond, Virginia-based company said it had net ...